# Kaohsiung Medical University Chung-Ho Memorial Hospital

Organization · id `cardio:org-kaohsiung-medical-university-chung-ho-memorial-hospital` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 02xmkec90](<https://ror.org/02xmkec90>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 5 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 02xmkec90 by an exact name.

## The registry's words

- Sponsor name: Kaohsiung Medical University Chung-Ho Memorial Hospital
- Sponsor class: OTHER
- ROR name: Kaohsiung Medical University Chung-Ho Memorial Hospital

## Connected pages

- Sponsors: The Safety and Efficacy of Cilostazol in Ischemic Stroke Patients With Peripheral Arterial Disease (SPAD Study) (`cardio:ct-nct01188824`)
- Sponsors: The Impact of Mobile APP Intervention ( iCKD APP) on Chronic Kidney Disease Care (`cardio:ct-nct03649516`)
- Sponsors: A Model of Computer-assisted Prescription of Erythropoiesis-stimulating Agents (ESA) in Patients Under Hemodialysis (`cardio:ct-nct04185519`)
- Sponsors: Use of a Novel Artificial Intelligence Assisted Platform to Assess Optimal Dosing and Treatment Strategy of Erythropoiesis-stimulating Agents (ESA) in Hemodialysis Patients (`cardio:ct-nct05032651`)
- Sponsors: Using AR Dental Care Training System in HE on Periodontal Status, Blood Sugar Control and QoL in Patients With T2DM (`cardio:ct-nct05941468`)

## Provenance

Content hash: 8a71e15b5049b80eefef00227e0f5261ecf002b7184485dd224f80fcfdc25b59
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
